Prominent bradycardia in a COVID-19 patient receiving Remdesivir: a case report

Remdesivir is a commonly used antiviral drug to treat COVID-19. Remdesivir has some side effects; however, whether it has any effect on cardiac is rarely reported. A 44-year-old woman with symptomatic confirmed COVID-19 was treated with intravenous remdesivir 200 mg on day one and followed with 100...

Full description

Bibliographic Details
Main Authors: Sidhi Laksono Purwowiyoto, Grace Trifena Hosea
Format: Article
Language:Indonesian
Published: Universitas Muhammadiyah Surabaya 2022-07-01
Series:Qanun Medika: Jurnal Kedokteran Fakultas Kedokteran Universitas Muhammadiyah Surabaya
Subjects:
Online Access:http://journal.um-surabaya.ac.id/index.php/qanunmedika/article/view/9379
_version_ 1798040414300667904
author Sidhi Laksono Purwowiyoto
Grace Trifena Hosea
author_facet Sidhi Laksono Purwowiyoto
Grace Trifena Hosea
author_sort Sidhi Laksono Purwowiyoto
collection DOAJ
description Remdesivir is a commonly used antiviral drug to treat COVID-19. Remdesivir has some side effects; however, whether it has any effect on cardiac is rarely reported. A 44-year-old woman with symptomatic confirmed COVID-19 was treated with intravenous remdesivir 200 mg on day one and followed with 100 mg remdesivir until day five. Three days after the treatment, she had significant bradycardia shown on the electrocardiography; however, the patient had no complaint or symptom regarding the bradycardia. Based on the discussion with the cardiology team, it was decided to cease remdesivir and replace it with oseltamivir, and the ECG showed some improvement. Remdesivir is a drug that should be used safely and cannot be taken at home, as there may be side effects left unaware.
first_indexed 2024-04-11T22:07:18Z
format Article
id doaj.art-9e8fa9935aa1403084f6b4c14d759bd0
institution Directory Open Access Journal
issn 2541-2272
2548-9526
language Indonesian
last_indexed 2024-04-11T22:07:18Z
publishDate 2022-07-01
publisher Universitas Muhammadiyah Surabaya
record_format Article
series Qanun Medika: Jurnal Kedokteran Fakultas Kedokteran Universitas Muhammadiyah Surabaya
spelling doaj.art-9e8fa9935aa1403084f6b4c14d759bd02022-12-22T04:00:40ZindUniversitas Muhammadiyah SurabayaQanun Medika: Jurnal Kedokteran Fakultas Kedokteran Universitas Muhammadiyah Surabaya2541-22722548-95262022-07-016210.30651/jqm.v6i2.93794160Prominent bradycardia in a COVID-19 patient receiving Remdesivir: a case reportSidhi Laksono PurwowiyotoGrace Trifena HoseaRemdesivir is a commonly used antiviral drug to treat COVID-19. Remdesivir has some side effects; however, whether it has any effect on cardiac is rarely reported. A 44-year-old woman with symptomatic confirmed COVID-19 was treated with intravenous remdesivir 200 mg on day one and followed with 100 mg remdesivir until day five. Three days after the treatment, she had significant bradycardia shown on the electrocardiography; however, the patient had no complaint or symptom regarding the bradycardia. Based on the discussion with the cardiology team, it was decided to cease remdesivir and replace it with oseltamivir, and the ECG showed some improvement. Remdesivir is a drug that should be used safely and cannot be taken at home, as there may be side effects left unaware.http://journal.um-surabaya.ac.id/index.php/qanunmedika/article/view/9379remdesivir, bradycardia, covid-19
spellingShingle Sidhi Laksono Purwowiyoto
Grace Trifena Hosea
Prominent bradycardia in a COVID-19 patient receiving Remdesivir: a case report
Qanun Medika: Jurnal Kedokteran Fakultas Kedokteran Universitas Muhammadiyah Surabaya
remdesivir, bradycardia, covid-19
title Prominent bradycardia in a COVID-19 patient receiving Remdesivir: a case report
title_full Prominent bradycardia in a COVID-19 patient receiving Remdesivir: a case report
title_fullStr Prominent bradycardia in a COVID-19 patient receiving Remdesivir: a case report
title_full_unstemmed Prominent bradycardia in a COVID-19 patient receiving Remdesivir: a case report
title_short Prominent bradycardia in a COVID-19 patient receiving Remdesivir: a case report
title_sort prominent bradycardia in a covid 19 patient receiving remdesivir a case report
topic remdesivir, bradycardia, covid-19
url http://journal.um-surabaya.ac.id/index.php/qanunmedika/article/view/9379
work_keys_str_mv AT sidhilaksonopurwowiyoto prominentbradycardiainacovid19patientreceivingremdesiviracasereport
AT gracetrifenahosea prominentbradycardiainacovid19patientreceivingremdesiviracasereport